SCHEMBL18656173

SCHEMBL18656173

Cc1ccc(CSCc2ccc(C)c(C)c2)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MAPT P10636 3/20 0.39
CYP2C9 P11712 1/20 0.39
ACE P12821 1/20 0.39
ALDH1A1 P00352 3/20 0.39
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
TNF P01375 1/20 0.36
NOD1 Q9Y239 1/20 0.36
LMNA P02545 3/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.35
ACHE P22303 2/20 0.34
BCHE P06276 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21241111 0.89 CYP1A2 (0.42) CYP1A2CYP3A4CYP2D6CYP2C19NPC1
SCHEMBL24108926 0.83 CYP1A2 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19NPC1
SCHEMBL20432633 0.81 CYP1A2 (0.44) CYP1A2CYP3A4CYP2D6CYP2C19NPC1
SCHEMBL29190942 0.79 CYP3A4 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19MAPT
SCHEMBL31371688 0.76 ESR1 (0.61) CYP1A2CYP3A4CYP2D6CYP2C19NPC1
SCHEMBL311076 0.76 ESR1 (0.61) CYP1A2CYP3A4CYP2D6CYP2C19NPC1
SCHEMBL30876036 0.76 ESR1 (0.61) CYP1A2CYP3A4CYP2D6CYP2C19NPC1
SCHEMBL29380988 0.76 PTGS1 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19NPC1
SCHEMBL311370 0.76 PTGS1 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19NPC1
SCHEMBL29597103 0.76 PTGS1 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200392331-A1 POLYCARBONATE COPOLYMER BLENDS, ARTICLES FORMED THEREFROM, AND METHODS OF MANUFACTURE SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2020-12-17 US disclosed
US-10377860-B2 Polyetherimides, methods of manufacture, and articles formed therefrom SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-08-13 US disclosed
US-10329421-B2 Polycarbonate compositions, method of manufacture thereof, and articles therefrom SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-06-25 US disclosed
US-20180086548-A1 ROUNDED EXTERIOR DIAMETER ADJUSTABLE SHIPPING CONTAINER, SYSTEM, AND METHOD FOR SHIPPING FREIGHT WITH THE CONTAINER MADE OF REINFORCED THERMOPLASTIC FIBER, ARTICLES, COMPOSITIONS FOR THE MANUFACTURE OF THE ARTICLES, METHODS OF MANUFACTURE, AND ARTICLES FORMED THEREFROM HEATH STEPHAN D (US) 2018-03-29 US disclosed
US-20170086285-A1 CIRCUIT ASSEMBLIES AND METHOD OF MANUFACTURE THEREOF SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10377860-B2 Polyetherimides, methods of manufacture, and articles formed therefrom PBRM1, WEE1, WASF2 CYP1A2 1016/4885CYP3A4 617/4885CYP2D6 472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.